Sort
261,768 grants matching “gene therapy”
Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection
$1,185,932Sergei V Kotenko · Rbhs-New Jersey Medical School · R01 · FY2015 · AI
Integrative Neuroscience Initiative on Alcoholism
$1,185,912George F Koob · Scripps Research Institute, The · U01 · FY2011 · AA
Genetic Modification of Muscle In Aging and Disease
$1,185,714University Of Michigan At Ann Arbor · P01 · FY2004 · AG
Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection
$1,185,617Sergei V Kotenko · Rbhs-New Jersey Medical School · R01 · FY2014 · AI
Bio-Therapies for the Treatment of Cancer
$1,185,606David Fitzgerald · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Growth Regulation and Therapy of Leukemias and Lymphomas
$1,185,541Subbarao Bondada · University Of Kentucky · P01 · FY2006 · CA
Driving Medical Projects (4 of 4)
$1,185,500Edward Mark Scolnick · Broad Institute, Inc. · RL1 · FY2009 · GM
Expansion of Cardiac and Hematopoietic Pregenitors by Wnt and Notch
$1,185,375Irwin Bernstein · Fred Hutchinson Cancer Research Center · U01 · FY2014 · HL
Growth Regulation and Therapy of Leukemias and Lymphomas
$1,185,331Subbarao Bondada · University Of Kentucky · P01 · FY2007 · CA
Genetic Predisposition & Prevention of Neural Tube Defects (NTDs)
$1,185,300Margaret Elizabeth Ross · Weill Medical Coll Of Cornell Univ · R01 · FY2009 · NS
CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral Dynamics
$1,185,192Owen W. Pornillos · University Of Utah · U54 · FY2022 · AI
Bay Area Team Against Resistance
$1,185,025Trever G Bivona · University Of California, San Francisco · U54 · FY2020 · CA
Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure
$1,184,950Sharon Riddler · University Of Pittsburgh At Pittsburgh · U01 · FY2021 · AI
Rat Resource and Research Center
$1,184,656John K. Critser · University Of Missouri-Columbia · P40 · FY2008 · RR
RARE DISEASE CRC FOR NEW THERAPIES AND NEW DIAGNOSTICS
$1,184,520Arthur L. Beaudet · Baylor College Of Medicine · U54 · FY2007 · RR
Translational Research Studies in Clinical Trials of Novel Therapeutics for Sarco
$1,184,449Gary K Schwartz · Sloan-Kettering Inst Can Research · RC2 · FY2010 · CA
Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)
$1,184,364Jeffrey Statland · University Of Kansas Medical Center · U01 · FY2024 · NS
Controlling Hematopoietic Lineage Commitment from ESC to Platelets
$1,184,306Beverly J Torok-Storb · Fred Hutchinson Cancer Research Center · U01 · FY2012 · HL
Coordinating center for the NCI small cell lung cancer research consortium
$1,184,296Charles M Rudin · Sloan-Kettering Inst Can Research · U24 · FY2017 · CA
Regulatory T Cells in Allogeneic Transplantation
$1,184,266Robert S Negrin · Stanford University · RC2 · FY2009 · HL
Collaborative African Genomics Network (CAFGEN)
$1,184,259Gabriel Anabwani · Botswana Baylor Child/Clincal Ctr/Excell · U54 · FY2015 · AI
Inherited Neurophathies Consortium (RDCRC)
$1,184,254Michael E Shy · University Of Iowa · U54 · FY2013 · NS
Modulation of Therapeutic Response
$1,184,062James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
Gene Therapy for Inherited Blood Disorders
$1,183,964Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
Cellular In vivo Imaging
$1,183,945Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA